Clinical trialNCT02141672CompletedPhase 2Interventional

AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)

SponsorAurinia Pharmaceuticals Inc.Enrollment265Lupus Nephritis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mary Anne Dooley, MD, MPH
University of North Carolina, Chapel Hill
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

86 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bangladesh

Aura-Lv Site
Dhaka, Bangladesh
Aura-Lv Site
Dhaka, Bangladesh

Belarus

Aura-Lv Site
Minsk, Belarus
Aura-Lv Site
Minsk, Belarus
Aura-Lv Site
Minsk, Belarus
Aura-Lv Site
Vitebsk, Belarus

Bulgaria

Aura-L Site
Plovdiv, Bulgaria
Aura-Lv Site
Sofia, Bulgaria
Aura-Lv Site
Sofia, Bulgaria
Aura-Lv Site
Varna, Bulgaria

China

Aura-Lv Site
Hong Kong, China

Ecuador

Aura-Lv Site
Guayaquil, Ecuador
Aura-Lv Site
Quito, Ecuador

Georgia

Aura-Lv Site
Tbilisi, Georgia
Aura-Lv Site
Tbilisi, Georgia

Guatemala

Aura-Lv Site
Guatemala City, Guatemala

Mexico

Aura-Lv Site
Guadalajara, Mexico
Aura-Lv Site
Mexicali, Mexico
Aura-Lv Site
Oaxaca City, Mexico
Aura-Lv Site
Tlalpan, Mexico
Aura-Lv Site
Tlalpan, Mexico

Philippines

Aura-Lv Site
Angeles City, Philippines
Aura-Lv Site
Batangas, Philippines
Aura-Lv Site
Cebu City, Philippines
Aura-Lv Site
Davao City, Philippines
Aura-Lv Site
Manila, Philippines
Aura-Lv Site
Manila, Philippines
Aura-Lv Site
Manila, Philippines
Aura-Lv Site
Quezon City, Philippines

Poland

Aura-Lv Site
Katowice, Poland
Aura-Lv Site
Radom, Poland
Aura-Lv Site
Warsaw, Poland
Aura-Lv Site
Wroclaw, Poland

Russia

Aura-Lv Site
Kazan', Russia
Aura-Lv Site
Kemerovo, Russia
Aura-Lv Site
Kemerovo, Russia
Aura-Lv Site
Moscow, Russia
Aura-Lv Site
Moscow, Russia
Aura-Lv Site
Omsk, Russia
Aura-Lv Site
Orenburg, Russia

46 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2014
Primary completion: 31 Jul 2016
Completion: 31 Jan 2017
Last update posted: 18 May 2021
Registered enrollment: 265
Registry id: NCT02141672

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.